Nexiam (Esomeprazole)

Esomeprazole, the active ingredient in Nexiam, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is employed in the management of acid‑related gastrointestinal disorders in adults, providing relief from heartburn and promoting healing of damaged mucosa.

GNH USA supplies Nexiam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide.

Esomeprazole is used to treat conditions associated with excessive gastric acid secretion. - Gastroesophageal reflux disease (GERD): alleviates heartburn and promotes healing of esophageal irritation. - Erosive esophagitis: facilitates mucosal repair and reduces further acid damage. - Peptic ulcer disease: supports ulcer healing and prevents recurrence. - Helicobacter pylori eradication (as part of combination therapy): enhances bacterial clearance by reducing gastric acidity. - Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid in this rare endocrine disorder.

Esomeprazole may be associated with a range of adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools that may be self‑limiting. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach region.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis requiring medical attention. - Acute interstitial nephritis: kidney inflammation presenting with reduced urine output. - Hypersensitivity reactions: rash, angioedema or anaphylaxis.

When prescribing or dispensing esomeprazole, several safety considerations should be observed. - Assess renal function: dose adjustment may be needed in severe impairment. - Evaluate for CYP2C19 interactions: genetic variability can affect drug levels. - Monitor long‑term use: prolonged therapy has been linked to vitamin B12 deficiency. - Use caution in elderly patients: increased risk of fractures and infections. - Store at ambient temperature: keep below 25 °C, retain original packaging and protect from moisture.

Esomeprazole can affect the pharmacokinetics of several concomitant medicines.

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced absorption due to increased gastric pH. - Clopidogrel: decreased antiplatelet effect from CYP2C19 inhibition.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, requiring closer monitoring. - Digoxin: possible increase in serum levels, monitor for toxicity. - Methotrexate (high dose): reduced renal clearance, watch for toxicity.